C

CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament

27 employees

CQDM is a drug discovery company that brings together researchers in academia, biotechs and the pharma industry.

Investor insights

Sectors invested in

Biotechnology5
Therapeutics3
Health Care2
ALS1
Health Diagnostics1
Market Research1
Nanotechnology1
Chemical1
Pharmaceutical1
Life Science1
Biopharma1
probiotcs1
Neurology1
Neuroscience1

Funding rounds participated in

$1.1M sweet spot round size

Most of their 7 investments are in rounds between $840K and $1.5M

Investor type

Accelerator

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Precompetitive research
Drug discovery
Pharmaceutical
Biopharmaceutical R&D
Drug development

Date founded

2008

Investments made

O

Oragenics, Inc raised undisclosed on June 5, 2023

Investors: CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament

g

giiant pharma Inc. raised $12M on May 21, 2021

Investors: Anges Québec, AQC Capital, Genesys Capital, Theodorus Investment Funds, Amplitude Ventures and CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament

n

nplex biosciences inc. raised $1M on July 16, 2020

Investors: CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament

I

ImStar Therapeutics Inc. raised $1.1M on February 9, 2017

Investors: Brain Canada and CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament

E

Encycle Therapeutics Inc raised $840K on June 16, 2015

Investors: CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament

U

Undisclosed raised $1.5M on June 8, 2015

Investors: Brain Canada and CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament

U

Undisclosed raised $490K on September 22, 2014

Investors: Ontario Centres of Excellence and CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament

FAQ